References
- AIOM-AIRTum. [The number of cancer in Italy 2019]. [Italian]. Brescia: Intermedia Editore; 2019. Available at: www.medinews.it
- AIOM Linee guida. [Breast neoplasms, 2019]. [Italian]. [internet]. 2019. [cited 2020 Oct 14]. Available at: https://www.aiom.it/linee-guida-aiomneoplasie-della-mammella-2019
- Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials Lancet 2011; 378: 1707-16. doi: 10.1016/S0140-6736(11)61629-2
- Hickey BE, James ML, Lehman M, Hider PN, Jeffery M, Francis DP, et al. Fraction size in radiation therapy for breast conservation in early breast cancer. Cochrane Database Syst Rev, 2016; 7: CD003860. doi: 10.1002/14651858.CD003860.pub4.
- Valle LF, Agarwal S, Bickel KE, Herchek HA, Nalepinski DC, Kapadia NS. Hypofractionated whole breast radiotherapy in breast conservation for early-stage breast cancer: a systematic review and meta-analysis of randomized trials. Breast Cancer Res Treat 2017; 162: 409-17. doi: 10.1007/ s10549-017-4118-7
- Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 2013; 14: 1269-77. doi: 10.1016/S1470-2045(13)70497-2
- Maluta S, Dall’Oglio S, Goer DA, Marciai N. Intraoperative electron radiotherapy (IOERT) as an alternative to standard whole breast irradiation: only for low-risk subgroups? Breast Care 2014; 9: 102-6. doi: 10.1159/000362392
- Sedlmayer F, Reitsamer R, Wenz F, Sperk E, Fussl C, Kaiser J, et al. Intraoperative radiotherapy (IORT) as boost in breast cancer. Radiat Oncol 2017; 12: 23. doi: 10.1186/s13014-016-0749-9
- Fastner G, Gaisberger C, Kaiser J, Scherer P, Ciabattoni A, Petoukhova A, et al. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer. Radiother Oncol 2020; 149: 150-15. doi: 10.1016/j.radonc.2020.04.059
- Russo G, Casarino C, Arnetta G, Candiano G, Stefano A, Alongi F, et al. Dose distribution changes with shielding disc misalignments and wrong orientations in breast IOERT: a Monte Carlo-GEANT4 and experimental study. J Appl Clin Med Phys 2012; 13: 74-92 doi: 10.1120/jacmp.v13i5.3817
- Vidali C, Severgnini M, Urbani M, Toscano L, Perulli A, Bortul M. FMECA application to intraoperative electron beam radiotherapy procedure as a quality method to prevent and reduce patient’s risk in conservative surgery for breast cancer. Front Med 2017; 4: 138 doi: 10.3389/fmed.2017.00138
- Correa C, Harris EE, Leonardi MC, Smith BD, Taghian AG, Thompson AM, et al. Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol 2017; 7: 73-9. doi: 10.1016/j.prro.2016.09.007
- Sedlmayer F, Fastner G, Sedlmayer F. Intra-operative electron boost and hypofractionated whole-breast irradiation during breast-conserving treatment (BCT) (HIOB). ClinicalTrials.gov Identifier: NCT01343459. [internet]. [cited 2020 Oct 13]. Available at: https://clinicaltrials.gov/ct2/show/NCT01343459
- Fastner G, Reitsamer R, Urbanski B, Kopp P, Murawa D, Adamczyk B, et al. Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): first results of a prospective multicenter trial (NCT01343459). Radiother Oncol 2020; 146: 136-42. doi: 10.1016/j.radonc.2020.02.001
- Severgnini M, de Denaro M, Bortul M, Vidali C, Beorchia A. In vivo dosimetry and shielding disk alignment verification by EBT3 GAFCHROMIC film in breast IOERT treatment. J Appl Clin Med Phys 2015; 16: 112-20. doi: 10.1120/jacmp.v16i1.5065
- Ciocca, M, Cantone MC, Veronese I, Cattani F, Pedroli G, Molinelli S, et al. Application of failure mode and effects analysis to intraoperative radiation therapy using mobile electron linear accelerators. Int J Radiat Oncol Biol Phys 2012; 82: e305-11. doi: 10.1016/j.ijrobp.2011.05.010
- López-Tarjuelo J, Bouché-Babiloni A, Santos-Serra A, Morillo-Macías V, Calvo FA, Kubyshin Y, et al. Failure mode and effect analysis oriented to risk-reduction interventions in intraoperative electron radiation therapy: the specific impact of patient transportation, automation, and treatment planning availability. Radiother Oncol 2014; 113: 283-9 doi: 10.1016/j. radonc.2014.11.012
- Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-6. doi: 10.1016/0360-3016(95)00060-C
- Rubin P, Constine LS, Fajardo LF, Phillips TF, Wasserman TH. RTOG Late Effects Working Group. Overview of late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 1995; 31: 1041-2. doi: 10.1016/0360-3016(95)00057-6
- Valdivieso-Casique MF, Rodríguez R, Rodríguez-Bescós S, Lardíes D, Guerra P, Ledesma MJ, et al. RADIANCE − a planning software for intra-operative radiation therapy. Transl Cancer Res 2015; 4: 196-209. doi: 10.3978/j. issn.2218-676X.2015.04.05
- Fastner G, Sedlmayer F, Merz F, Deutschmann H, Reitsamer R, Menzel C, et al. IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis. Radiother Oncol 2013; 108: 279-86. doi: 10.1016/j.radonc.2013.05.031
- Kaiser J, Reitsamer R, Kopp P, Gaisberger C, Kopp M, Fischer T, et al. Intraoperative electron radiotherapy (IOERT) in the treatment of primary breast cancer. Breast Care 2018; 13: 162-7. doi: 10.1159/000489637
- Merrick HW 3rd, Hager E, Dobelbower RR Jr. Intraoperative radiation therapy for breast cancer. Surg Oncol Clin N Am 2003; 12: 1065-78. doi: 10.1016/s1055-3207(03)00098-x
- Lemanski C, Azria D, Thezenas S, Gutowski M, Saint-Aubert B, Rouanet P, et al. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results. Int J Radiat Oncol Biol Phys 2006; 64: 1410-5. doi: 10.1016/j.ijrobp.2005.10.025
- Wong WW, Pockaj BA, Vora SA, Halyard MY, Gray RJ, Schild SE. Six-year outcome of a prospective study evaluating tumor bed boost with intraoperative electron irradiation followed by whole-breast irradiation for early-stage breast cancer. Breast J 2014; 20: 125-30. doi:10.1111/tbj.12235
- Konig L, Lang K, Heil J, Golatta M, Major G, Krug D, et al. Acute toxicity and early oncological outcomes after intraoperative electron radiotherapy (IOERT) as boost followed by whole breast cancer patients – first clinical results from a single center. Front Oncol 2019; 9: 384. doi: 10.3389/ fonc.2019.00384
- Ivaldi GB, Leonardi MC, Orecchia R, Zerini D, Morra A, Galimberti V, et al. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women. Int J Radiat Oncol Biol Phys 2008; 72: 485-93. doi: 10.1016/j.ijrobp.2007.12.038
- Bhandari T, Babaran W, Forouzannia A, Williams V, Harness J, Carpenter M, et al. A prospective phase I comparison of toxicity and cosmesis outcomes of single-fraction IORT and hypofractionated radiotherapy with IORT boost in early-stage breast cancer. Brachytherapy 2017; 16: 1232-1238.e2. doi: 10.1016/j.brachy.2017.09.002